Viewing Study NCT03194893


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-01-06 @ 7:19 AM
Study NCT ID: NCT03194893
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-25
First Post: 2017-06-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module